0NR Stock Overview
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Uniphar plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.46 |
| 52 Week High | €3.44 |
| 52 Week Low | €1.98 |
| Beta | 0.76 |
| 1 Month Change | -1.60% |
| 3 Month Change | -4.28% |
| 1 Year Change | -12.46% |
| 3 Year Change | -16.33% |
| 5 Year Change | n/a |
| Change since IPO | 123.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0NR | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | -3.3% | -1.6% | 1.2% |
| 1Y | -12.5% | -3.9% | 2.0% |
Return vs Industry: 0NR underperformed the German Healthcare industry which returned -3.9% over the past year.
Return vs Market: 0NR underperformed the German Market which returned 2% over the past year.
Price Volatility
| 0NR volatility | |
|---|---|
| 0NR Average Weekly Movement | 6.8% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 0NR has not had significant price volatility in the past 3 months.
Volatility Over Time: 0NR's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 3,000 | Ger Rabbette | www.uniphar.ie |
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.
Uniphar plc Fundamentals Summary
| 0NR fundamental statistics | |
|---|---|
| Market cap | €697.55m |
| Earnings (TTM) | €44.82m |
| Revenue (TTM) | €2.55b |
15.6x
P/E Ratio0.3x
P/S RatioIs 0NR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0NR income statement (TTM) | |
|---|---|
| Revenue | €2.55b |
| Cost of Revenue | €2.16b |
| Gross Profit | €389.98m |
| Other Expenses | €345.17m |
| Earnings | €44.82m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 15.28% |
| Net Profit Margin | 1.76% |
| Debt/Equity Ratio | 70.7% |
How did 0NR perform over the long term?
See historical performance and comparison